Vericel Corp

Common Name
Vericel
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
357
Ticker
VCEL
Exchange
NASDAQ/NMS
Website
vcel.com
Description
Vericel Corporation is a biopharmaceutical company focused on the development and commercialization of innovative cellular therapies for patients with severe diseases and conditions. The company's pri...

Vericel's Financial Statements Preview

Below are the financial statements of Vericel, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in thousands of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
74,520a
69,088a
Restricted cash
10,529a
17,778a
Short-term investments
41,693a
40,469a
Accounts receivable, net
61,375a
58,356a
Inventory
17,373a
13,087a
Other current assets
7,287a
6,853a
Total current assets
212,777a
205,631a
Property and equipment, net
103,161a
41,635a
Intangible assets, net
6,250a
6,875a
Right-of-use assets
70,098a
73,462a
Long-term investments
39,880a
25,283a
Other long-term assets
556a
771a
Total assets
432,722a
353,657a
Liabilities and shareholders’ equity
Current liabilities
Accounts payable
23,848a
22,347a
Accrued expenses
17,065a
17,215a
Current portion of operating lease liabilities
9,257a
6,187a
Other current liabilities
116a
0a
Total current liabilities
50,286a
45,749a
Operating lease liabilities
89,593a
81,856a
Other long-term liabilities
876a
100a
Total liabilities
140,755a
127,705a
Shareholders’ equity
Common stock, no par value
684,778a
629,229a
Accumulated other comprehensive loss
4a
-100a
Accumulated deficit
-392,815a
-403,177a
Total shareholders’ equity
291,967a
225,952a
Total liabilities and shareholders’ equity
432,722a
353,657a
Download Data

Verified Sources Behind Vericel’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vericel’s data sources below and access millions more through our Disclosure Search.

a. Vericel's 10-K 2024
a. Vericel's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?